Detalhe da pesquisa
1.
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
Br J Haematol
; 189(1): 84-96, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31702836
2.
A MALT lymphoma prognostic index.
Blood
; 130(12): 1409-1417, 2017 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28720586
3.
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes.
Hematol Oncol
; 2018 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29722049
4.
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Oncol
; 18(3): 297-311, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28139405
5.
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.
Lancet
; 387(10036): 2402-11, 2016 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27080498
6.
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.
N Engl J Med
; 370(11): 997-1007, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24450857
7.
Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study.
Haematologica
; 102(5): 903-909, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126962
8.
Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.
Haematologica
; 102(1): 150-159, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27758822
9.
Scientific rationale for extrapolation of biosimilar data across cancer indications: case study of CT-P10.
Future Oncol
; 13(15s): 45-53, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482699
10.
Clinical development of CT-P10 and other biosimilar cancer therapeutics.
Future Oncol
; 13(15s): 31-44, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482700
11.
Monotherapy with pixantrone in histologically confirmed relapsed or refractory aggressive B-cell non-Hodgkin lymphoma: post-hoc analyses from a phase III trial.
Br J Haematol
; 174(5): 692-9, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27118109
12.
A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma.
Br J Haematol
; 173(5): 722-30, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27010483
13.
Time has come for immunotherapy in PTCL.
Blood
; 123(20): 3059-60, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24832935
14.
The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Haematologica
; 101(2): 115-208, 2016 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26819058
15.
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.
Am J Hematol
; 91(11): 1096-1101, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465588
16.
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas.
Lancet Oncol
; 16(15): e555-e567, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26545844
17.
Primary refractory diffuse large B cell lymphoma in the rituximab era.
Curr Opin Oncol
; 27(5): 377-83, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26258271
18.
TP53 and outcome in DLBCL: not only the coding region.
Blood
; 121(22): 4433-4, 2013 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23723442
19.
Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia.
Invest New Drugs
; 33(2): 423-31, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25600050
20.
Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
Br J Haematol
; 164(5): 659-67, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24274024